International Journal of Cardiology
Volume 142, Issue 1 , Pages 50-55 , 25 June 2010

Effects of chronic testosterone administration on myocardial ischemia, lipid metabolism and insulin resistance in elderly male diabetic patients with coronary artery disease

  • Alessandra Cornoldi

      Affiliations

    • Cardiovascular Research Unit Department of Medical Sciences, San Raffaele IRCCS — Rome, Italy
    • ,
  • Giuseppe Caminiti

      Affiliations

    • Cardiovascular Research Unit Department of Medical Sciences, San Raffaele IRCCS — Rome, Italy
    • ,
  • Giuseppe Marazzi

      Affiliations

    • Cardiovascular Research Unit Department of Medical Sciences, San Raffaele IRCCS — Rome, Italy
    • ,
  • Cristiana Vitale

      Affiliations

    • Cardiovascular Research Unit Department of Medical Sciences, San Raffaele IRCCS — Rome, Italy
    • ,
  • Roberto Patrizi

      Affiliations

    • Cardiovascular Research Unit Department of Medical Sciences, San Raffaele IRCCS — Rome, Italy
    • ,
  • Maurizio Volterrani

      Affiliations

    • Cardiovascular Research Unit Department of Medical Sciences, San Raffaele IRCCS — Rome, Italy
    • ,
  • Marco Miceli

      Affiliations

    • Cardiovascular Research Unit Department of Medical Sciences, San Raffaele IRCCS — Rome, Italy
    • ,
  • Massimo Fini

      Affiliations

    • Cardiovascular Research Unit Department of Medical Sciences, San Raffaele IRCCS — Rome, Italy
    • ,
  • Giovanni Spera

      Affiliations

    • Department of Medical Physiopatology, University “La Sapienza”, Policlinico Umberto I, Rome, Italy
    • ,
  • Giuseppe Rosano

      Affiliations

    • Cardiovascular Research Unit Department of Medical Sciences, San Raffaele IRCCS — Rome, Italy
    • Corresponding Author InformationCorresponding author. Cardiovascular Research Unit, Department of Medical Sciences, San Raffaele — Roma, TOSINVEST Sanita', via della Pisana 235, 00163 Roma, Italy. Tel.: +39 06 660581; fax: +39 06 52244512.

Received 19 September 2008 ,Accepted 13 December 2008.

References 

  1. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med. 1976;85:447–452
  2. Nasr A, Breckwoldt M. Estrogen replacement therapy and cardiovascular protection: lipid mechanisms are the tip of an iceberg. Gynecol Endocrinol. 1998;12:43–59
  3. Sullivan ML, Martinez CM, Gennis P, Gallagher EJ. The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis. 1998;41:1–15
  4. English KM, Mandour O, Steeds RP, Diver MJ, Jones TH, Channer KS. Men with coronary artery disease have lower levels of androgens that men with normal coronary angiograms. Eur Heart J. 2000;21:890–894
  5. Phillips GB, Pinkernell BH, Jing TY. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb. 1994;14:701–706
  6. Jones DB, Higgins B, Billet JS, et al. The effect of testosterone replacement on plasma lipids and apolipoproteins. Eur J Clin Invest. 1989;19:438–441
  7. Uyanik BS, Ari Z, Gumus B, Yigitoglu MR, Arslan T. Beneficial effects of testosterone undecanoate on the lipoproteins profiles in healthy elderly men. A placebo controlled study. Jpn Heart J. 1997;38:73–82
  8. Hanke H, Lenz C, Hess B, Spindler KD, Weidemann W. Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wall. Circulation. 2001;103:1382–1385
  9. Nathan L, Shi W, Dinh H, et al. Testosterone inhibits early atherogenesis by conversion to estradiol: critical role of aromatase. Proc Natl Acad Sci USA. 2001;98:3589–3593
  10. Malkin CJ, Pugh PJ, Jones RD, Jones TH, Channer KS. Testosterone as a protective factor against atherosclerosis-immunomodulation and influence upon plaque development and stability. J Endocrinol. 2003;178:373–380
  11. Rosano GM, Leonardo F, Pagnotta P, et al. Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation. 1999;99:1666–1670
  12. Webb CM, Adamson DL, De Zeigler D, Collins P. Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. Am J Cardiol. 1999;83:437–439
  13. English KM, Steeds RP, Hugh Jones T, Diver MJ, Channer KS. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina. Circulation. 2000;102:1906–1911
  14. Kiraly CL. Androgenic–anabolic steroid effects on serum and skin surface lipids, on red cells, and on liver enzymes. Int J Sports Med. 1988;9:249–252
  15. Shephard RJ, Killinger D, Fried T. Responses to sustained use of anabolic steroid. Br J Sports Med. 1977;11:170–173
  16. Inigo MA, Arrimadas E, Arroyo D. 43 cycles of anabolic steroid treatment studied in athletes: the uses and secondary effects. Rev Clin Esp. 2000;200:133–138
  17. Elbers JM, Giltay EJ, Teerlink T, et al. Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin Endocrinol (Oxf). 2003;58:562–571
  18. Harada N, Sasano H, Murakami H, Ohkuma T, Nagura H, Takagi Y. Localized expression of aromatase in human vascular tissues. Circ Res. 1999;84:1285–1291
  19. Sasano H, Murakami H, Shizawa S, Satomi S, Nagura H, Harada N. Aromatase and sex steroid receptors in human vena cava. Endocr J. 1999;46:233–242
  20. Diano S, Horvath TL, Mor G, et al. Aromatase and estrogen receptor immunoreactivity in the coronary arteries of monkeys and human subjects. Menopause. 1999;6:21–28
  21. Komesaroff PA, Fullerton M, Esler MD, Dart A, Jennings G, Sudhir K. Low-dose estrogen supplementation improves vascular function in hypogonadal men. Hypertension. 2001;38:1011–1016
  22. Davis SR, Bradbury J, Bell R, Johns JA. Acute administration of conjugated equine oestrogen does not improve exercise-induced myocardial ischaemia in men with coronary artery disease. Intern Med J. 2003;33:221–224
  23. Sih R, Morley JE, Kaiser FE, Perry HM, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12-months randomized controlled trial. J Clin Endocrinol Metab. 1997;82:1661–1667
  24. Holmang S, Marin P, Lindstedt G, Hedelin H. Effects of long-term oral testosterone undecanoate treatment on prostate volume and serum prostate-specific antigen concentration in eugonadal middle aged men. Prostate. 1993;23:99–106
  25. Snyder PJ, Peachey H, Hannoush P, et al. Effects of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab. 1999;84:1966–1972
  26. Nair KS, Rizza RA, O'Brien P, et al. DHEA in elderly women and DHEA or testosterone in elderly men. NEJM. 2006;355:1647–1659
  27. Kenny AM, Prestwood KM, Gruman CA, Marcello KM, Raisz LG. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci. 2001;56A:M266–M272
  28. Cherrier MM, Asthana S, Plymate S, et al. Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology. 2001;57:80–88
  29. Wu FC, von Eckardstein A. Androgens and coronary artery disease. Endocr Rev. 2003;24:183–1617
  30. Kapoor D, Goodwin E, Channer KS, Jones TH. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2006;154:899–906
  31. Boneva Z, Christov VG. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male. 2003;6:1–7
  32. Katznelson L, Robinson MW, Coyle CL, Lee H, Farrell CE. Effects of modest testosterone supplementation and exercise for 12 weeks on body composition and quality of life in elderly men. Eur J Endocrinol. 2006;155:867–875
  33. Coats AJ. Ethical authorship and publishing. Int J Cardiol. 2009;131:149–150

PII: S0167-5273(08)01487-3

doi: 10.1016/j.ijcard.2008.12.107

International Journal of Cardiology
Volume 142, Issue 1 , Pages 50-55 , 25 June 2010

Article Tools

* Image Usage & Resolution